NCT04607941

Brief Summary

The objective of the study is to identify socio-demographic factors, behaviors and practices associated with infection with SARS-CoV-2 to help determine where and how patients mostly get infected with SARS-CoV-2. It is a case-control study including :

  • cases identified by the nationwide system of positive SARS-CoV-2 tests (COVID-19 diagnosis information system, SIDEP) (currently limited to qRT-PCR) and invited to participate by the National Health Insurance (CNAM) which hosts the data from the nationwide test system;
  • controls included via Ipsos, a polling institute with access to personal data from a panel from which they will include controls matched on age (divided into 10-year categories), gender and geographic area (departement);
  • cases will be offered to invite a person they live with to participate in the study offering another case-control analysis inside a household. These participants will be required to report the result of the test as recommended by contact tracing guidelines to determine whether they are cases or controls. Data will be collected via a self-administered online questionnaire. Some of the participants will be called for a complementary telephone questionnaire to measure reliability of online retrieved data and explore more specific aspects of SARS-CoV-2 transmission.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
766,818

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2020

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 20, 2020

Completed
7 days until next milestone

Study Start

First participant enrolled

October 27, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 29, 2020

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2022

Completed
Last Updated

April 6, 2023

Status Verified

April 1, 2022

Enrollment Period

1.9 years

First QC Date

October 20, 2020

Last Update Submit

April 5, 2023

Conditions

Keywords

Covid19behaviorepidemiologyquestionnaires

Outcome Measures

Primary Outcomes (1)

  • Odds-ratios of SARS-CoV-2 infection on socio-demographic factors, behaviors and practices and visited places reported by the participants in the online questionnaire

    Odds-ratios of SARS-CoV-2 infection on socio-demographic factors, behaviors and practices and visited places through case-control analyses.

    1 year

Secondary Outcomes (9)

  • Proportion of cases infected in family environment by SARS-CoV-2 reported by participants in the phone interview

    1 year

  • Proportion of cases infected in family environment by SARS-CoV-2 reported by participants in the online questionnaire

    1 year

  • Proportion of cases infected in professional environment by SARS-CoV-2 reported by participants in the phone interview

    1 year

  • Proportion of cases infected in professional environment by SARS-CoV-2 reported by participants in the online questionnaire

    1 year

  • Level of adherence to mask-wearing reported in the phone interview

    1 year

  • +4 more secondary outcomes

Study Arms (3)

Cases

Subjects diagnosed as positive for SARS-CoV-2 infection

Other: QuestionnairesOther: Phone interviews

Close Subjects

Subjects living within the same household as cases: * close cases if tested positive for SARS-CoV-2 following contact tracing recommendations * close controls if tested negative for SARS-CoV-2 following contact tracing recommendations

Other: QuestionnairesOther: Phone interviews

Control Subjects

Controls selected within the population to allow for an age, gender and location of residence-matched analysis with cases

Other: QuestionnairesOther: Phone interviews

Interventions

Self-administered questionnaires

CasesClose SubjectsControl Subjects

A small amount of subjects will be selected at random for phone interviews.

CasesClose SubjectsControl Subjects

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Index cases: People with positive SARS-CoV-2 test identified by the National Health Insurance (CNAM) in the nationwide database SIDEP (COVID-19 diagnosis information system), which is a system that collects data from tests performed in all testing facilities in France. Only people who have given their e-mail address to the CNAM will be contacted. Close subjects: Invited by index cases with whom they live. "Distant" controls: Selected by Ipsos' panel on age, gender and location of residence criteria (to allow for matched case-control analysis) and Health Care Workers.

You may qualify if:

  • All participants:
  • Aged 18 years or more
  • Agreeing to participate in the study
  • Index cases:
  • Cases identified by the National Health Insurance (CNAM) in the nationwide database SIDEP (COVID-19 diagnosis information system)
  • Positive SARS-CoV-2 RT-PCR on nasopharyngeal or throat swab (or another sample which state of the art considers that it indicates an active infection if positive)
  • "Distant" controls:
  • Selected by Ipsos among Ipsos' panel on age, gender and location of residence criteria (to allow for matched case-control analysis)
  • Health Care Workers
  • Close subjects:
  • People who live in the same household as a case and who have been invited to participate by that case
  • People who have had a RT-PCR test on nasopharyngeal or throat swab (or another sample which state of the art considers it indicates an active infection if positive) following diagnosis of the index case (following contact tracing recommendations), classified as:
  • close cases if test is positive
  • close controls if test is negative

You may not qualify if:

  • For all participants:
  • People under judicial protection measures ("sauvegarde de justice", "curatelle", "curatelle renforcée", "tutelle", ie various forms of curatorship under French law)
  • For related cases, related controls and "distant" controls:
  • People with a history of SARS-CoV-2 infection confirmed by RT-PCR or positive testing of anti-SARS-CoV-2 antibodies with serology (for related cases: before the current episode)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Caisse Nationale d'Assurance Maladie

Paris, France

Location

IPSOS

Paris, France

Location

Related Publications (6)

  • Lievre G, Sicsic J, Galmiche S, Charmet T, Fontanet A, Mueller J. Are psychological attitudes towards vaccination an expression of personality? A cross-sectional study on COVID-19 vaccination in France. BMC Public Health. 2025 Jan 17;25(1):209. doi: 10.1186/s12889-025-21364-9.

  • Galmiche S, Charmet T, Rakover A, Cheny O, Omar F, David C, Mailles A, Carrat F, Fontanet A. Risk of SARS-CoV-2 infection in professional settings, shops, shared transport, and leisure activities in France, 2020-2022. BMC Public Health. 2024 Sep 4;24(1):2411. doi: 10.1186/s12889-024-19651-y.

  • Lievre G, Sicsic J, Galmiche S, Charmet T, Fontanet A, Mueller JE. Are the 7C psychological antecedents associated with COVID-19 vaccine behaviours beyond intentions? A cross-sectional study on at-least-one-dose and up-to-date vaccination status, and uptake speed among adults in France. Vaccine. 2024 May 22;42(14):3288-3299. doi: 10.1016/j.vaccine.2024.04.024. Epub 2024 Apr 19.

  • Rakover A, Galmiche S, Charmet T, Cheny O, Omar F, David C, Martin S, Mailles A, Fontanet A. Source of SARS-CoV-2 infection: results from a series of 584,846 cases in France from October 2020 to August 2022. BMC Public Health. 2024 Jan 30;24(1):325. doi: 10.1186/s12889-024-17772-y.

  • Galmiche S, Charmet T, Rakover A, Schaeffer L, Cheny O, von Platen C, Omar F, David C, Mailles A, Carrat F, Fontanet A. Risk of SARS-CoV-2 Infection Among Households With Children in France, 2020-2022. JAMA Netw Open. 2023 Sep 5;6(9):e2334084. doi: 10.1001/jamanetworkopen.2023.34084.

  • Galmiche S, Charmet T, Madec Y, Rakover A, Schaeffer L, Cheny O, Omar F, Martin S, Mailles A, Carrat F, Fontanet A. Reduction of SARS-CoV-2 intra-household child-to-parent transmission associated with ventilation: results from a case-control study. BMC Public Health. 2023 Jun 26;23(1):1240. doi: 10.1186/s12889-023-16144-2.

MeSH Terms

Conditions

COVID-19Behavior

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Arnaud Fontanet, Pr

    Institut Pasteur

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 20, 2020

First Posted

October 29, 2020

Study Start

October 27, 2020

Primary Completion

September 30, 2022

Study Completion

September 30, 2022

Last Updated

April 6, 2023

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations